<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> increases in the <z:hpo ids='HP_0011009'>acute</z:hpo> phase of ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> and from the <z:hpo ids='HP_0011009'>acute</z:hpo> to the convalescent phase, suggesting that hyper-homocysteinaemia may be a consequence rather than a causal factor </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore we measured <z:chebi fb="0" ids="17230">homocysteine</z:chebi> plasma levels in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients in order to investigate possible correlations of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> with <z:hpo ids='HP_0001297'>stroke</z:hpo> severity and clinical outcome </plain></SENT>
<SENT sid="2" pm="."><plain>Further we looked for eventual differences in <z:hpo ids='HP_0001297'>stroke</z:hpo> subtypes </plain></SENT>
<SENT sid="3" pm="."><plain>We prospectively studied plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> patients admitted to the <z:hpo ids='HP_0001297'>stroke</z:hpo> unit of our department </plain></SENT>
<SENT sid="4" pm="."><plain>Seven hundred and seventy-five ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, 39 cerebral haemorrhages and 421 healthy control subjects have been enrolled </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> severity and clinical outcome were measured with the Scandinavian <z:hpo ids='HP_0001297'>Stroke</z:hpo> Scale, the Rankin Scale and the Barthel Index </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> severity by linear stepwise regression analysis was not an independent determinant of plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> was not correlated with outcome measured by the Barthel Index </plain></SENT>
<SENT sid="8" pm="."><plain>Mean plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> of both ischaemic and haemorrhagic <z:hpo ids='HP_0001297'>stroke</z:hpo> was significantly higher than controls (p&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> had an adjusted odds ratios (OR) of 4.2 (95% CI 2.77-6.54) for ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> and of 3.69 (95% CI 1.90-7.17) for haemorrhagic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Compared with the lowest quartile, the upper quartile was associated with an adjusted OR of ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> due to small artery disease of 17.4 (95% CI 6.8-44.3) </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> in the <z:hpo ids='HP_0011009'>acute</z:hpo> phase of <z:hpo ids='HP_0001297'>stroke</z:hpo> was not associated with <z:hpo ids='HP_0001297'>stroke</z:hpo> severity or outcome </plain></SENT>
<SENT sid="12" pm="."><plain>Elevated plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> in the <z:hpo ids='HP_0011009'>acute</z:hpo> phase of <z:hpo ids='HP_0001297'>stroke</z:hpo> was associated with both ischaemic and haemorrhagic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>Higher levels are associated with higher risk of small artery disease subtype of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>